Is there a causal relation between the administration of gadolinium based contrast media and the development of nephrogenic systemic fibrosis (NSF)?
about
Four-dimensional flow magnetic resonance imaging in cirrhosis.Design of ProCAs (protein-based Gd(3+) MRI contrast agents) with high dose efficiency and capability for molecular imaging of cancer biomarkersMolecular imaging of EGFR/HER2 cancer biomarkers by protein MRI contrast agentsMacromolecules, dendrimers, and nanomaterials in magnetic resonance imaging: the interplay between size, function, and pharmacokinetics.The fate of Gd and chelate following intravenous injection of gadodiamide in rats.Gadolinium deposits could influence the course of encapsulating peritoneal sclerosis.Comprehensive evaluation of the physicochemical properties of Ln(III) complexes of aminoethyl-DO3A as pH-responsive T(1) -MRI contrast agents.Minimizing risk of nephrogenic systemic fibrosis in cardiovascular magnetic resonanceComparison of myocardial perfusion estimates from dynamic contrast-enhanced magnetic resonance imaging with four quantitative analysis methods.Effect of abrupt substitution of gadobenate dimeglumine for gadopentetate dimeglumine on rate of allergic-like reactions.Gd-encapsulated carbonaceous dots with efficient renal clearance for magnetic resonance imaging.Gadolinium and nephrogenic systemic fibrosis: association or causation.Gadolinium-based contrast agents and nephrogenic systemic fibrosis: a systematic review and meta-analysis.4D flow imaging with MRI.Imaging as an End Point in Ischemia Trials.4D flow MRI.Gadolinium-based contrast agents in pediatric magnetic resonance imaging.Estimating myocardial perfusion from dynamic contrast-enhanced CMR with a model-independent deconvolution method.Improved 3D phase contrast MRI with off-resonance corrected dual echo VIPRSalicylic acid analogues as chemical exchange saturation transfer MRI contrast agents for the assessment of brain perfusion territory and blood-brain barrier opening after intra-arterial infusion.Technical note: A simple and effective CO 2 delivery system for angiography using a blood bag.Imaging in the time of NFD/NSF: do we have to change our routines concerning renal insufficiency?Hemodynamic analysis of renal artery stenosis using computational fluid dynamics technology based on unenhanced steady-state free precession magnetic resonance angiography: preliminary results.Cerebral blood volume mapping with ferumoxytol in dynamic susceptibility contrast perfusion MRI: Comparison to standard of care.Who should have pelvic vessel imaging prior to renal transplantation?Reduction/dissolution of a beta-MnOOH nanophase in the ferritin cavity to yield a highly sensitive, biologically compatible magnetic resonance imaging agentA follow-up of four cases of nephrogenic systemic fibrosis: is gadolinium the specific trigger?
P2860
Q26769606-F3CB5F24-590C-47DF-8BB6-F38787D54EE0Q28235682-5075761C-4F22-4610-9BA0-1D6E16073743Q28304646-E9E96FEC-6A41-44C2-8894-B725C838A2ADQ33847006-8B72D779-FA4C-45D8-A57A-5B88F88B9DC3Q33899096-FE00A7D8-31D9-4CA5-A146-6D2835CD1F2DQ33967882-AC469A90-BE6C-4831-ACAC-7AB72F3C0FD4Q35109777-376A7668-1054-4928-B542-CAEC2E3719F6Q36130156-F0C3D677-AADB-4CF6-A24B-98FC11DFE9A9Q36430108-F5700ACE-5A8F-4AF9-A45C-244459114F2CQ36628982-643CC682-A509-4615-A467-FF9E73C92D84Q36948085-F388DB67-E30C-4C0B-B8F5-188C28838B45Q37067538-7ED0F36E-99BA-4FDD-AC5C-3C3839E0E682Q37308825-4441BDA8-0E33-4EA7-8540-4A1079F77029Q37717699-E4C44635-4552-4CA4-9536-F85CDDD48D51Q37863002-F4DBB32D-D318-467F-BFD3-D174DFD75E0CQ38054634-7150B8E6-4EC7-44E0-8CAB-84544FC77B81Q39242162-CEBB4C78-C793-4167-B95B-7A15C6212BEEQ41189424-DE986403-94B7-40ED-92AF-22CC24BD261AQ41959516-E3D203E7-C281-437C-8C0B-263224F8BF36Q42011053-B45277EC-E34D-485A-8E1C-C7CA5ADDF43FQ42118148-AB2D9CAD-D895-4FCD-8504-8EC73C38FC6BQ42947961-FB81E311-FB6E-4446-94FA-391894471ECAQ44184360-879D5D86-8565-4D6C-A387-0FA2122C34C6Q47191283-9297C2AA-AFCB-4AE6-A045-6818DB8CC410Q52847971-3DCB6BDE-FA62-40A3-B06A-2844E4CD7182Q57185848-428A8D7A-CA9A-420F-8907-8BE665233170Q57186435-07319355-8A4C-4604-922E-F403B18E3724
P2860
Is there a causal relation between the administration of gadolinium based contrast media and the development of nephrogenic systemic fibrosis (NSF)?
description
2006 nî lūn-bûn
@nan
2006 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Is there a causal relation bet ...... genic systemic fibrosis (NSF)?
@ast
Is there a causal relation bet ...... genic systemic fibrosis (NSF)?
@en
Is there a causal relation bet ...... genic systemic fibrosis (NSF)?
@nl
type
label
Is there a causal relation bet ...... genic systemic fibrosis (NSF)?
@ast
Is there a causal relation bet ...... genic systemic fibrosis (NSF)?
@en
Is there a causal relation bet ...... genic systemic fibrosis (NSF)?
@nl
prefLabel
Is there a causal relation bet ...... genic systemic fibrosis (NSF)?
@ast
Is there a causal relation bet ...... genic systemic fibrosis (NSF)?
@en
Is there a causal relation bet ...... genic systemic fibrosis (NSF)?
@nl
P2093
P1433
P1476
Is there a causal relation bet ...... genic systemic fibrosis (NSF)?
@en
P2093
P356
10.1016/J.CRAD.2006.09.003
P407
P577
2006-11-01T00:00:00Z